EUVIMEDEUVIMED entdecken
Crossref

Bridging therapy by azacitidine in a patient with atypical chronic myeloid leukemia, followed by human leukocyte antigen- haploidentical stem cell transplantation

Miyo Goto, Nobuaki Fukushima, Makoto Ito, Shiori Iida, Yuma Kawamura, Shun Ukai, Ken Sagou, Akio Kohno, Kazutaka Ozeki

Japanese Journal of Transplantation and Cellular Therapy · 2021

DOI: 10.7889/tct-21-003 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Japanese Journal of Transplantation and Cellular Therapy, 2021. Verfasst von Miyo Goto und 8 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Goto, M., Fukushima, N., Ito, M., Iida, S., Kawamura, Y., Ukai, S., Sagou, K., Kohno, A., & Ozeki, K. (2021). Bridging therapy by azacitidine in a patient with atypical chronic myeloid leukemia, followed by human leukocyte antigen- haploidentical stem cell transplantation. Japanese Journal of Transplantation and Cellular Therapy. https://doi.org/10.7889/tct-21-003

Vancouver

Goto M, Fukushima N, Ito M, Iida S, Kawamura Y, Ukai S, et al. Bridging therapy by azacitidine in a patient with atypical chronic myeloid leukemia, followed by human leukocyte antigen- haploidentical stem cell transplantation. Japanese Journal of Transplantation and Cellular Therapy. 2021. doi:10.7889/tct-21-003

BibTeX
@article{Goto2021,
  author = {Goto, Miyo and Fukushima, Nobuaki and Ito, Makoto and Iida, Shiori and Kawamura, Yuma and Ukai, Shun and Sagou, Ken and Kohno, Akio and Ozeki, Kazutaka},
  title = {Bridging therapy by azacitidine in a patient with atypical chronic myeloid leukemia, followed by human leukocyte antigen- haploidentical stem cell transplantation},
  journal = {Japanese Journal of Transplantation and Cellular Therapy},
  year = {2021},
  doi = {10.7889/tct-21-003}
}
Kostenlos starten →